VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm’s products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
59
Frequently Asked Questions
What is Market Cap of Vivus Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Vivus Inc market cap is $1.61M.
What is the 52-week high for Vivus Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vivus Inc 52 week high is $4.75 as of September 09, 2025.
What is the 52-week low for Vivus Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vivus Inc 52 week low is $0.089 as of September 09, 2025.
What is Vivus Inc stock price today?
Vivus Inc stock price today is $0.09.
What was Vivus Inc stock price yesterday?
Vivus Inc stock price yesterday was $0.105.
What is the PE ratio of Vivus Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Vivus Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Vivus Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Vivus Inc P/B ratio is -0.0130.
What is Vivus Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Vivus Inc's EBITDA is 42.82.
What is the 50-day moving average of Vivus Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Vivus Inc 50-day moving average is $0.5231.
